AYLA Trademark

Trademark Overview


On Friday, March 6, 2020, a trademark application was filed for AYLA with the United States Patent and Trademark Office. The USPTO has given the AYLA trademark a serial number of 88823839. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 26, 2020. This trademark is owned by Integral Health Holdings, LLC. The AYLA trademark is filed in the Insurance & Financial Services category with the following description:

Financial and hedge fund investment services; providing venture capital, development capital, private equity and investment funding; venture capital advisory services; pharmaceutical, medical, scientific, and biopharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software used for the sequencing and analyses of genomic data, transcriptomic data, proteomic data, DNA, RNA, and protein; software used to predict, integrate and create data models; computer databases of genomic sequences for scientific research, na...
ayla

General Information


Serial Number88823839
Word MarkAYLA
Filing DateFriday, March 6, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 26, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFinancial and hedge fund investment services; providing venture capital, development capital, private equity and investment funding; venture capital advisory services; pharmaceutical, medical, scientific, and biopharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software used for the sequencing and analyses of genomic data, transcriptomic data, proteomic data, DNA, RNA, and protein; software used to predict, integrate and create data models; computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; predictive digital computer modeling for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 12, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntegral Health Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Monday, October 26, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, October 26, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2020NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 14, 2020ASSIGNED TO EXAMINER
Thursday, March 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM